Pazopanib and Vinflunine in Urothelial Cancer of the Bladder

NCT01265940 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Advanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy.

Interventions

DRUG: Pazopanib as add-on to vinflunine

Sponsor

Prof. Dr. Thomas Otto